Future challenges and opportunities with fluorine in drugs?

dc.contributor.author	O'Hagan, David
dc.contributor.author	Young, Robert John
dc.date.accessioned	2023-06-28T12:30:13Z
dc.date.available	2023-06-28T12:30:13Z
dc.date.issued	2023-07-01
dc.identifier	287283464
dc.identifier	884a729a-c9b8-43a6-8672-f772a8c57881
dc.identifier	85161846993
dc.identifier.citation	O'Hagan , D & Young , R J 2023 , ' Future challenges and opportunities with fluorine in drugs? ' , Medicinal Chemistry Research , vol. 32 , pp. 1231-1234 . https://doi.org/10.1007/s00044-023-03094-y	en
dc.identifier.issn	1054-2523
dc.identifier.other	ORCID: /0000-0002-0510-5552/work/137914795
dc.identifier.uri	https://hdl.handle.net/10023/27820
dc.format.extent	4
dc.format.extent	623006
dc.language.iso	eng
dc.relation.ispartof	Medicinal Chemistry Research	en
dc.subject	QD Chemistry	en
dc.subject	RM Therapeutics. Pharmacology	en
dc.subject	T-NDAS	en
dc.subject	MCC	en
dc.subject.lcc	QD	en
dc.subject.lcc	RM	en
dc.title	Future challenges and opportunities with fluorine in drugs?	en
dc.type	Journal article	en
dc.contributor.institution	University of St Andrews. Institute of Behavioural and Neural Sciences	en
dc.contributor.institution	University of St Andrews. EaSTCHEM	en
dc.contributor.institution	University of St Andrews. Biomedical Sciences Research Complex	en
dc.contributor.institution	University of St Andrews. School of Chemistry	en
dc.identifier.doi	10.1007/s00044-023-03094-y
dc.description.status	Peer reviewed	en